drugset / Trial / NCT01326117

Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis

NCT01326117

NaSingle-groupOpen-labelTreatment

Summary

The investigators hypothesize that in adult patients with diabetic gastroparesis with Type 1 diabetes (HbA1c ≤ 10.5%), daily tadalafil use will significantly improve gastric emptying compared to baseline as measured by gastric emptying time.

Timeline

Start
2011-04
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tadalafil Small molecule 5 mg

Indications